<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Aachen_Blog_14-07-15-01"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Aachen/Blog/14-07-15-01">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Aachen/Blog/14-07-15-01&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Aachen/Blog/14-07-15-01&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Aachen/Blog/14-07-15-01&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Aachen/Blog/14-07-15-01" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Aachen/Blog/14-07-15-01</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV class="navDiv" style="top:14px; position:fixed; z-index: 1; border-bottom-style: solid; border-bottom-width: 3px; border-bottom-color: #bf1521;"><NAV style="width: 1250px;"><UL align="left" style=""><LI style="width:129px"><A href="https://2014.igem.org/Team:Aachen/Project">Project</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/2D_Biosensor">2D Biosensor</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/FRET_Reporter">The REACh Construct</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/Model">Modeling</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Project/Measurement_Device"><I>WatsOn</I></A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/Project/Gal3">Galectin-3</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/OD/F device">OD/F Device</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Parts">Parts</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Achievements">Achievements</A></LI></UL><LI style="width:216px"><A href="https://2014.igem.org/Team:Aachen/Interlab_Study">Interlab Study</A></LI><LI style="width:250px"><A href="https://2014.igem.org/Team:Aachen/PolicyPractices">Policy &amp; Practices</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Kaiser-Karls-Gymnasium">Kaiser-Karls-Gymnasium</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Neanderlab">NEAnderLab</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/Collaborations/MakerFaire">MakerFaire</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Safety">Safety</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/PolicyPractices/Economics">Economical View</A></LI><LI style="border-bottom:2px solid; border-bottom-color: white;"><A href="https://2014.igem.org/Team:Aachen/PolicyPractices/BioBrickIntellectualProperty">BBa Intellectual Property</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Blog">Blog</A></LI><LI style="width:215px"><A href="https://2014.igem.org/Team:Aachen/Collaborations">Collaborations</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Meetup">Aachen Meetup</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Bielefeld">Bielefeld</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Methane_Sensor">Braunschweig</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Freiburg">Freiburg</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Collaborations/Heidelberg">Heidelberg</A></LI><LI style="width:157px"><A href="https://2014.igem.org/Team:Aachen/Notebook">Notebook</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Wetlab">Wetlab</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Protocols">Protocols</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Engineering">Engineering</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Software">Software</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/LabEquipment">Equipment</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Notebook/Index">Abbreviations</A></LI><LI style="width:109px"><A href="https://2014.igem.org/Team:Aachen/Attributions">Team</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#members">Members</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#instructors">Instructors</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#partners">Partners</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/Attributions#support">Attributions</A></LI><LI><A href="https://2014.igem.org/Team:Aachen/SecretHappenings"><I>Mr Holmes</I></A></LI></NAV></DIV><DIV id="contentdiv" style="margin-left: auto; margin-right: auto; width: 100%; position: absolute; bottom: 15px; top: 60px;"><TABLE class="transbg" width="100%" cellspacing="0"><TBODY><TR><TD class="contentcell" width="95%" align="justify"><H1><SPAN class="mw-headline" id="Blog_.2319_-_Noneffective_Antibiotics_.28Part_III.29:_Have_the_Pharma_Giants_Lost_The_Race.3F"> Blog #19 - Noneffective Antibiotics (Part III): Have the Pharma Giants Lost The Race? </SPAN></H1><P>By <A href="/wiki/index.php?title=User:NBailly&amp;action=edit&amp;redlink=1" class="new" title="User:NBailly (page does not exist)">NBailly</A> 15:39, July 15 2014 (CDT)
</P></TD></TR><TR><TD><B>David and Goliath</B>Small Companies have taken leading position in antibiotics research. Picture by  LegalIT Lawyers.
</TD></TR></TBODY></TABLE></DIV><P>It is not the big pharma companies that will develop the desperately needed new generation of antibiotics that can even cope with multi-resistant bacteria such as MRSA. Instead, some smaller companies who never gave up researching this field are now future market leaders. As the German business news magazine <A href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-krankenhaeuser-als-sammelbecken-von-multiresistenten-keimen/10076108-2.html">Wirtschaftswoche</A> reported this June, it is companies like the British-Swedish Astra Zeneca or Hoffmann-La Roche spin off Basilea that are now in a leading position.
</P><P>Astra Zeneca, for example, brought the very effective antibiotic Ceftarolin to the European market. Ceftarolin can also cope with MRSA. But this is not the company’s only success: Another highly interesting remedy, Avibactam, was developed. This drug tricks multi-resistant bacteria into lowering their defense against antibiotics. In a combined treatment with the broad-spectrum antibiotic cephalosporin, it is running through the last two phases of authorizing trials on humans. Astra Zeneca hopes this treatment will be admitted to urinary tract infections and pneumonia by 2016. Basilea’s fifth generation cephalosporin, Ceftobiprol, has also been admitted to help people with pneumonia. It can kill a multitude of killer germs at the same time, and is expected to yield more than one billion dollars on the market.
</P><P>The latter example shows that a lot of money can be made with antibiotics nowadays when the old ones keep of failing against multi-resistant strains. Although big pharma companies like Bayer, Roche or Sanofi have realized that by now, it might be too late to catch up to the leading position. While Astra Zeneca increased its department in 2009 through buying the French Novexel, Sanofi and co. gave up on many promising ideas that are now fruitfully developed by their spun offs. 
</P></DIV><DIV class="footerDiv" align="center" style="margin-bottom:-10px; background:#0069b3;"><CENTER><A class="footerCenter" href="https://2014.igem.org/Team:Aachen/Contact">Contact</A><A class="footerCenter" href="https://2014.igem.org/Team:Aachen/Disclaimer">Disclaimer</A></CENTER></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Aachen/Blog/14-07-15-01">http://2014.igem.org/Team:Aachen/Blog/14-07-15-01</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Aachen/Blog/14-07-15-01" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Aachen/Blog/14-07-15-01" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Aachen/Blog/14-07-15-01&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Aachen/Blog/14-07-15-01&amp;oldid=59752" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></BODY></HTML>